Overview
Viscogliosi & Company provides a broad range of financing solutions to issuers, principally in the musculoskeletal/orthopedic sector of the healthcare industry through underwritings; distribution of private placement securities to institutions and high net worth investors; and investment banking advisory services.

The Company is the investment banking subsidiary of Viscogliosi Brothers, LLC, an independent merchant bank specializing in venture capital and private equity investments in the musculoskeletal/orthopedic sectors of the healthcare industry.  Viscogliosi Brothers, established in New York City in 1999, creates, builds and finances innovations developed by surgeons focused on “life changing” orthopedic and spinal technologies.  The founding partners (Anthony G. Viscogliosi, John J. Viscogliosi, and Marc R. Viscogliosi) have more than 35 years of collective experience concentrated in the musculoskeletal orthopedic companies.  They have pioneered innovative financial, strategic and management initiatives from startup, seed, and development stage through exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.  Since inception, Viscogliosi Brothers has participated in more than 40 transactions in the orthopedic and spine sectors with an aggregate approximate transaction value of $1 billion.  Viscogliosi Brothers also owns Musculoskeletal Clinical Regulatory Advisers, LLC,  a full service advisory firm that provides regulatory strategy; clinical monitoring; data management; preclinical testing; reimbursement strategy; and quality assurance services to orthopedic and other healthcare companies.


Mission
The experienced professionals at Viscogliosi recognize the investment banking needs of both publicly and privately owned musculoskeletal/orthopedic device companies and their shareholders.  Viscogliosi’s mission is to provide to the owners of these high growth companies the full range of sophisticated services they require to take the fullest advantage of their growth opportunities.  Viscogliosi’s main mission is to provide value added financial advice to musculoskeletal/orthopedic companies and act as their agent in raising capital.  Viscogliosi does not offer research, institutional trading or other capital market supports, preferring to emphasize to our client companies the benefits of the independence and absence of conflicts of interest in our advice and services.

    Viscogliosi’s Mission - Financing “Life Changing” Healthcare Technologies

  • Develop and implement capital sourcing strategies for musculoskeletal/orthopedic and other healthcare companies.
  • Provide specialized investment banking advisory services to musculoskeletal/orthopedic and other healthcare companies.
  • Advice and assist management and ownership of musculoskeletal/orthopedic and other healthcare companies in achieving their goals and objectives.


Competitive Advantage

Viscogliosi is one of the few recognized experts in the specialized area of investment banking for orthopedic companies.


    Viscogliosi’s Competitive Advantage – We Understand Orthopedics

  • Our professionals attend 20-25 orthopedic surgeon-focused and disease-specific conferences annually.
  • Our professionals view several surgeries annually in operating rooms around the world, standing shoulder-to-shoulder with key innovation-leading spine, neuro, and orthopedic surgeons.
  • Our professionals maintain regular contact with the more than 140 musculoskeletal opinion thought leaders, including leading orthopedic and neurosurgeons, international product distributors and musculoskeletal industry personnel.
  • We maintain a unique proprietary library that contains comprehensive information on more than 1,900 companies in the global musculoskeletal industry.
  • The professionals at Viscogliosi have developed more than 4,000 industry relationships and contacts for continued access to information regarding the musculoskeletal/orthopedic industries.